Skip to main content

Closed

BCRX: BioCryst Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

57thpctl

Volume

0.58×avg

Market Cap

2.28BUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

BioCryst Pharmaceuticals, Inc.

BCRXNASDAQ Global Select·USD·Closed

BioCryst Pharmaceuticals, Inc.

BCRXNASDAQ·USD·Closed

$8.98

−2.81%

$8.98

−$0.26 (2.81%)

52W Range

57thpctl

Volume

0.58×avg

Mkt Cap

2.28BUSD

P/E

-5.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings